(firstQuint)Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases.

 Study Design - the assessment of patients with multiple tumour sites with metastatic thyroid cancer to correlate the administered activity to absorbed dose.

 Patients will receive the standard therapy dose of 5.

5 GBq as per the hospital policy and there will be no change for the protocol purpose.

.

 Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases@highlight

The main purpose of the study is to establish a relationship between the administered activity of the radioiodine and absorbed dose in the tumor sites.

